U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT07531329) titled 'Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naive Men With Suspected Prostate Cancer' on March 11.
Brief Summary: Brief Summary This prospective, multicenter study evaluates whether delayed PSMA PET imaging improves diagnostic efficacy for detecting clinically significant prostate cancer (Gleason score >=7) compared with standard imaging in patients with suspected newly diagnosed prostate cancer. Each patient serves as their own control, with diagnostic performance compared between standard (60-minute) and delayed (2-3 hour) acquisitions.
Background PSMA PET has transformed prostate ...